List of Arcturus Therapeutics patents

Patents where

Current Assignee

Name

Arcturus Therapeutics

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 11685906 Compositions and methods for treating ornithine transcarbamylase deficiency	Patent 11685906 was granted and assigned to Arcturus Therapeutics on June, 2023 by the United States Patent and Trademark Office.	Arcturus Therapeutics	Arcturus Therapeutics	United States Patent and Trademark Office	11685906	June 27, 2023
‌ US Patent 10369232 Allele selective gene editing and uses thereof	Patent 10369232 was granted and assigned to Arcturus Therapeutics on August, 2019 by the United States Patent and Trademark Office.	Arcturus Therapeutics	Arcturus Therapeutics	United States Patent and Trademark Office	10369232	August 6, 2019
‌ US Patent 11407800 Translatable molecules and synthesis thereof	Patent 11407800 was granted and assigned to Arcturus Therapeutics on August, 2022 by the United States Patent and Trademark Office.	Arcturus Therapeutics	Arcturus Therapeutics	United States Patent and Trademark Office	11407800	August 9, 2022
‌ US Patent 9340789 UNA oligomer structures for therapeutic agents	Patent 9340789 was granted and assigned to Arcturus Therapeutics on May, 2016 by the United States Patent and Trademark Office.		Arcturus Therapeutics	United States Patent and Trademark Office	9340789	May 17, 2016
‌ US Patent 11015204 Synthesis and structure of high potency RNA therapeutics	Patent 11015204 was granted and assigned to Arcturus Therapeutics on May, 2021 by the United States Patent and Trademark Office.	Arcturus Therapeutics	Arcturus Therapeutics	United States Patent and Trademark Office	11015204	May 25, 2021
‌ US Patent 10487105 Trinucleotide MRNA cap analogs	Patent 10487105 was granted and assigned to Arcturus Therapeutics on November, 2019 by the United States Patent and Trademark Office.	Arcturus Therapeutics	Arcturus Therapeutics	United States Patent and Trademark Office	10487105	November 26, 2019
‌ US Patent 11434485 Synthetic transfer RNA with extended anticodon loop	Patent 11434485 was granted and assigned to Arcturus Therapeutics on September, 2022 by the United States Patent and Trademark Office.	Arcturus Therapeutics	Arcturus Therapeutics	United States Patent and Trademark Office	11434485	September 6, 2022
‌ US Patent 9303260 UNA duplex oligomers for therapeutics	Patent 9303260 was granted and assigned to Arcturus Therapeutics on April, 2016 by the United States Patent and Trademark Office.	Arcturus Therapeutics	Arcturus Therapeutics	United States Patent and Trademark Office	9303260	April 5, 2016
‌ US Patent 9297009 UNA oligomers targeting micro-RNA for therapeutics	Patent 9297009 was granted and assigned to Arcturus Therapeutics on March, 2016 by the United States Patent and Trademark Office.	Arcturus Therapeutics	Arcturus Therapeutics	United States Patent and Trademark Office	9297009	March 29, 2016
‌ US Patent 9051570 UNA oligomers for therapeutics	Patent 9051570 was granted and assigned to Arcturus Therapeutics on June, 2015 by the United States Patent and Trademark Office.	Arcturus Therapeutics	Arcturus Therapeutics	United States Patent and Trademark Office	9051570	June 9, 2015
‌ US Patent RE49233 Ionizable cationic lipid for RNA delivery	Patent RE49233 was granted and assigned to Arcturus Therapeutics on October, 2022 by the United States Patent and Trademark Office.	Arcturus Therapeutics	Arcturus Therapeutics	United States Patent and Trademark Office	RE49233	October 4, 2022
‌ US Patent 9580711 Lipid particles with asymmetric cationic lipids for RNA delivery	Patent 9580711 was granted and assigned to Arcturus Therapeutics on February, 2017 by the United States Patent and Trademark Office.	Arcturus Therapeutics	Arcturus Therapeutics	United States Patent and Trademark Office	9580711	February 28, 2017
‌ US Patent 9593077 Ionizable cationic lipid for RNA delivery	Patent 9593077 was granted and assigned to Arcturus Therapeutics on March, 2017 by the United States Patent and Trademark Office.	Arcturus Therapeutics	Arcturus Therapeutics	United States Patent and Trademark Office	9593077	March 14, 2017
‌ US Patent 9567296 Ionizable cationic lipid for RNA delivery	Patent 9567296 was granted and assigned to Arcturus Therapeutics on February, 2017 by the United States Patent and Trademark Office.	Arcturus Therapeutics	Arcturus Therapeutics	United States Patent and Trademark Office	9567296	February 14, 2017
‌ US Patent 9365610 Asymmetric ionizable cationic lipid for RNA delivery	Patent 9365610 was granted and assigned to Arcturus Therapeutics on June, 2016 by the United States Patent and Trademark Office.	Arcturus Therapeutics	Arcturus Therapeutics	United States Patent and Trademark Office	9365610	June 14, 2016
‌ US Patent 10526284 Ionizable cationic lipid for RNA delivery	Patent 10526284 was granted and assigned to Arcturus Therapeutics on January, 2020 by the United States Patent and Trademark Office.	Arcturus Therapeutics	Arcturus Therapeutics	United States Patent and Trademark Office	10526284	January 7, 2020
‌ US Patent 10980895 Ionizable cationic lipid for RNA delivery	Patent 10980895 was granted and assigned to Arcturus Therapeutics on April, 2021 by the United States Patent and Trademark Office.	Arcturus Therapeutics	Arcturus Therapeutics	United States Patent and Trademark Office	10980895	April 20, 2021
‌ US Patent 9670152 Ionizable cationic lipid for RNA delivery	Patent 9670152 was granted and assigned to Arcturus Therapeutics on June, 2017 by the United States Patent and Trademark Office.	Arcturus Therapeutics	Arcturus Therapeutics	United States Patent and Trademark Office	9670152	June 6, 2017
‌ US Patent 10227302 Ionizable cationic lipid for RNA delivery	Patent 10227302 was granted and assigned to Arcturus Therapeutics on March, 2019 by the United States Patent and Trademark Office.	Arcturus Therapeutics	Arcturus Therapeutics	United States Patent and Trademark Office	10227302	March 12, 2019
‌ US Patent 10421964 UNA oligomers and compositions for treating amyloidosis	Patent 10421964 was granted and assigned to Arcturus Therapeutics on September, 2019 by the United States Patent and Trademark Office.	Arcturus Therapeutics	Arcturus Therapeutics	United States Patent and Trademark Office	10421964	September 24, 2019
‌ US Patent 10383952 Ionizable cationic lipid for RNA delivery	Patent 10383952 was granted and assigned to Arcturus Therapeutics on August, 2019 by the United States Patent and Trademark Office.	Arcturus Therapeutics	Arcturus Therapeutics	United States Patent and Trademark Office	10383952	August 20, 2019
‌ US Patent 9896413 Ionizable cationic lipid for RNA delivery	Patent 9896413 was granted and assigned to Arcturus Therapeutics on February, 2018 by the United States Patent and Trademark Office.	Arcturus Therapeutics	Arcturus Therapeutics	United States Patent and Trademark Office	9896413	February 20, 2018
‌ US Patent 9962449 MultiLigand agent for drug delivery	Patent 9962449 was granted and assigned to Arcturus Therapeutics on May, 2018 by the United States Patent and Trademark Office.	Arcturus Therapeutics	Arcturus Therapeutics	United States Patent and Trademark Office	9962449	May 8, 2018
‌ US Patent 10399937 Ionizable cationic lipid for RNA delivery	Patent 10399937 was granted and assigned to Arcturus Therapeutics on September, 2019 by the United States Patent and Trademark Office.	Arcturus Therapeutics	Arcturus Therapeutics	United States Patent and Trademark Office	10399937	September 3, 2019
‌ US Patent 9951002 Ionizable cationic lipid for RNA delivery	Patent 9951002 was granted and assigned to Arcturus Therapeutics on April, 2018 by the United States Patent and Trademark Office.	Arcturus Therapeutics	Arcturus Therapeutics	United States Patent and Trademark Office	9951002	April 24, 2018

Results per page:

50 results

0 selected

50 results

0 selected